Challenges to mapping the health risk of hepatitis A virus infection

被引:64
|
作者
Hanafiah, Khayriyyah Mohd [2 ]
Jacobsen, Kathryn H. [1 ]
Wiersma, Steven T. [2 ]
机构
[1] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA
[2] WHO, Expanded Program Immunizat, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland
关键词
hepatitis A; geographic information systems; health risk maps; risk mapping; vaccine recommendations; global health; travel health; GEOREFERENCED DATA; SEROPREVALENCE; OUTBREAKS;
D O I
10.1186/1476-072X-10-57
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: World maps are among the most effective ways to convey public health messages such as recommended vaccinations, but creating a useful and valid map requires careful deliberation. The changing epidemiology of hepatitis A virus (HAV) in many world regions heightens the need for up-to-date risk maps. HAV infection is usually asymptomatic in children, so low-income areas with high incidence rates usually have a low burden of disease. In higher-income areas, many adults remain susceptible to the virus and, if infected, often experience severe disease. Results: Several challenges associated with presenting hepatitis A risk using maps were identified, including the need to decide whether prior infection or continued susceptibility more aptly indicates risk, whether to display incidence or prevalence, how to distinguish between different levels of risk, how to display changes in risk over time, how to present complex information to target audiences, and how to handle missing or obsolete data. Conclusion: For future maps to be comparable across place and time, we propose the use of the age at midpoint of population susceptibility as a standard indicator for the level of hepatitis A endemicity within a world region. We also call for the creation of an accessible active database for population-based age-specific HAV seroprevalence and incidence studies. Health risk maps for other conditions with rapidly changing epidemiology would benefit from similar strategies.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review
    Araujo de Almeida, Nathalia Alves
    de Paula, Vanessa Salete
    JOURNAL OF APPLIED MICROBIOLOGY, 2022, 132 (03) : 1616 - 1635
  • [42] Hepatitis C Virus Infection and Coinfection With Human Immunodeficiency Virus Challenges and Advancements in Management
    Hadigan, Colleen
    Kottilil, Shyamasundaran
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (03): : 294 - 301
  • [43] T cell epitope mapping of hepatitis B virus in chronic infection
    Viuff, Marie
    Tuefferd, Marianne
    Heeke, Christina
    Munk, Kamilla Kjaergaard
    Kadivar, Mohammad
    Lauer, Georg
    Bollekens, Jacques
    Hadrup, Sine Reker
    JOURNAL OF HEPATOLOGY, 2022, 77 : S271 - S272
  • [44] Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan
    Ruzibakiev, R
    Kato, H
    Ueda, R
    Yuldasheva, N
    Hegay, T
    Avazova, D
    Kurbanov, F
    Zalalieva, M
    Tuichiev, L
    Achundjanov, B
    Mizokami, M
    INTERVIROLOGY, 2001, 44 (06) : 327 - 332
  • [45] Acute hepatitis C virus infection: clinical update and remaining challenges
    Liu, Chen-Hua
    Kao, Jia-Horng
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (03) : 623 - 642
  • [46] Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges
    Yan, Yong-Ping
    Su, Hai-Xia
    Ji, Zhao-Hua
    Shao, Zhong-Jun
    Pu, Zhong-Shu
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (01) : 15 - 22
  • [47] Challenges in the management of HIV and hepatitis C virus co-infection
    Lee, W
    Dieterich, D
    DRUGS, 2004, 64 (07) : 693 - 700
  • [48] Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection
    Vermehren, Johannes
    Park, James S.
    Jacobson, Ira M.
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2018, 69 (05) : 1178 - 1187
  • [49] Challenges in the Management of HIV and Hepatitis C Virus Co-infection
    Winston Lee
    Douglas Dieterich
    Drugs, 2004, 64 : 693 - 700
  • [50] Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
    Reza Taherkhani
    Fatemeh Farshadpour
    World Journal of Hepatology, 2017, (33) : 1239 - 1252